• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:邱琨,刘琪,吴巧娜,刘晶磊,王宇佳,苏彦雷,孙殿兴,赵建元.棕矢车菊素对新型冠状病毒RNA聚合酶的抑制活性[J].药学研究,2026,45(2):130-133,149[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2643次   下载 883次 本文二维码信息
码上扫一扫!
棕矢车菊素对新型冠状病毒RNA聚合酶的抑制活性
邱琨1,刘琪2,吴巧娜1,刘晶磊2,王宇佳3,苏彦雷2,孙殿兴2,赵建元3
字体:加大+|默认|缩小-
(1.石家庄市第三医院,河北 石家庄 050011;2.联勤保障部队第九八〇医院,河北 石家庄 050082;3.中国医学科学院、北京协和医学院医药生物技术研究所,北京 100050)
摘要:
目的 探索黄酮类小分子棕矢车菊素对新型冠状病毒RNA聚合酶的抑制活性。方法 运用分子对接技术研究棕矢车菊素在RNA聚合酶活性位点的结合模式,判断棕矢车菊素是否可以牢固地结合于RNA聚合酶的核苷酸底物(nucleoside triphosphates, NTPs)通道而阻碍原底物的进入;而后利用细胞水平的新型冠状病毒RNA聚合酶催化反应体系检测棕矢车菊素对RNA聚合酶的抑制性药理活性。结果 棕矢车菊素可结合于RNA聚合酶的活性位点处,占据NTPs通道而阻碍核苷酸底物的进入,从而实现抑制RNA聚合酶核酸复制的药理作用。细胞水平的药理实验结果发现,棕矢车菊素对新型冠状病毒RNA聚合酶具有一定程度的抑制活性,活性弱于瑞德西韦,但细胞毒性低于瑞德西韦。结论 本实验结果显示棕矢车菊素具有一定的RNA聚合酶抑制活性,本实验结果可为抗新型冠状病毒药物研发提供参考。
关键词:  新型冠状病毒  RNA聚合酶  活性位点  棕矢车菊素  分子对接  活性测试
DOI:10.13506/j.cnki.jpr.2026.02.002
基金项目:河北省医学科研课题项目(No.20241370)
出版日期:2026-02-25
Inhibitory activity of jaceosidin on the SARS-CoV-2 RNApolymerase
QIU Kun1,LIU Qi2,WU Qiaona1,LIU Jinglei2,WANG Yujia3,SU Yanlei2,SUN Dianxing2,ZHAO Jianyuan3
(1.The Third Hospital of Shijiazhuang,Shijiazhuang 050011,China;2.The 980th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army,Shijiazhuang 050082,China;3.Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China)
Abstract:
Objective To explore the inhibitory activity of the flavonoid jaceosidin against the RNA polymerase of the novel coronavirus.Methods Molecular docking was first employed to investigate the binding mode of jaceosidin at the active site of RNA polymerase, to determine whether jaceosidin could stably bind to the NTPs channel and obstruct the entry of substrates. Subsequently, the inhibitory pharmacological activity of jaceosidin against RNA polymerase was evaluated using a cell-based assay system for the catalytic reaction of the novel coronavirus RNA polymerase. Results Jaceosidin exhibited favorable binding to the active site of RNA polymerase, occupying the NTPs channel and hindering the entry of nucleotides, thereby achieving pharmacological action to inhibit RNA polymerase-mediated nucleic acid replication. The results of pharmacological experiments at the cellular level demonstrated that jaceosidin possesses inhibitory activity against RNA polymerase, albeit with weaker activity compared to remdesivir. However, jaceosidin exhibited lower cytotoxicity compared to remdesivir.Conclusion The findings of this study indicate that jaceosidin exhibits inhibitory activity against RNA polymerase, providing a potential reference for the development of anti-novel coronavirus drugs.
Key words:  SARS-CoV-2  RNA polymerase  Active site  Jaceosidin  Molecular dock  Activity test
今日访问量:2270    总访问量:55338611
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司